Eμ‐MYC transgenic mice, which model Burkitt's lymphoma to a certain degree, develop monoclonal pro‐/pre‐B and immature B cell lymphomas between 4 and 7 months of age 27, 28. Here, MYC is linked to Burkitt lymphoma.